Presence of mEGFR ctDNA predicts a poor clinical outcome in lung adenocarcinoma
Background Circulating tumor DNA (ctDNA) is a biomarker for the selection of target agents in various malignancies. In this study, we examined the effect of ctDNA presence on the response to EGFR‐tyrosine kinase inhibitor (TKI) and on the prognosis in lung adenocarcinoma. Methods ctDNA of EGFR‐TKI s...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley
2019-12-01
|
| Edice: | Thoracic Cancer |
| Témata: | |
| On-line přístup: | https://doi.org/10.1111/1759-7714.13219 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|